Search Results - "Fåhraeus, Lars"

Predisposing factors for bacterial vaginosis, treatment efficacy and pregnancy outcome among term deliveries; results from a preterm delivery study by Larsson, P-G, Fåhraeus, Lars, Carlsson, Bodil, Jakobsson, Tell, Forsum, Urban

“…Bacterial vaginosis (BV) during pregnancy is associated with an increased risk of preterm delivery but little is known about factors that could predict BV. We…”
Get full text

Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen by Larsson, P‐G, Fåhraeus, L, Carlsson, B, Jakobsson, T, Forsum, U

“…Objective  To screen for bacterial vaginosis (BV) and to investigate the effect of treatment with vaginal clindamycin in order to observe the effect on late…”
Get full text

Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study by Larsson, P G, Platz-Christensen, J J, Dalaker, K, Eriksson, K, Fåhraeus, L, Irminger, K, Jerve, F, Stray-Pedersen, B, Wölner-Hanssen, P

“…Bacterial vaginosis (BV) and intermediate flora is known risk-factor for postoperative infection after surgical termination of pregnancy. Vaginal application…”
Get more information

Diagnosis of bacterial vaginosis: need for validation of microscopic image area used for scoring bacterial morphotypes by Larsson, P-G, Carlsson, B, Fåhraeus, L, Jakobsson, T, Forsum, U

“…Background: The diagnosis of bacterial vaginosis (BV) is often made according to Nugent’s classification, a scoring system based on bacterial counting of Gram…”
Get full text

Placental transfer of hydrochlorothiazide by Beermann, B, Fåhraeus, L, Groschinsky-Grind, M, Lindström, B

“…The concentrations of hydrochlorothiazide (HCT) in maternal and umbilical cord plasma and in amniotic fluid were determined at partus in 10 pregnancies. The…”
Get more information

Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy by Fåhraeus, L, Larsson-Cohn, U, Wallentin, L

“…In 19 healthy women the levels of plasma lipoprotein fractions were determined before conception, at exact gestational ages every six to 8 weeks during…”
Get more information

Lower Devonian Conodonts from the Michelle and Prongs Creek Formations, Yukon Territory by Fåhræus, Lars E.

“…Thirty-three conodont species are described from the Michelle Formation and the lower part of the Prongs Creek Formation, both of northern Yukon Territory…”
Get full text

Metabolic consequences of postmenopausal estrogen and progestogen treatment by Fåhraeus, L

Get more information

Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate by Fåhraeus, L, Sydsjö, A, Wallentin, L

“…Ten women with endometriosis were treated with medroxyprogesterone acetate (MPA), 150 mg intramuscularly every second week. After 2 weeks, there was a…”
Get more information

L-norgestrel and progesterone have different influences on plasma lipoproteins by Fåhraeus, L, Larsson-Cohn, U, Wallentin, L

“…Twenty-six postmenopausal women who had been on cutaneous oestradiol treatment for 3-6 months were given either 120 micrograms of 1-norgestrel (n = 13) or 300…”
Get more information

Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women by Fåhraeus, L, Larsson-Cohn, U

“…Thirty-eight post-menopausal women were randomly allocated to 6 months of treatment with either 2-4 mg of micronized oestradiol-17 beta taken orally or 3 mg of…”
Get more information

Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive by Larsson-Cohn, U, Fåhraeus, L, Wallentin, L, Zador, G

“…Lipids, high-density lipoprotein (HDL) cholesterol, and sex hormone-binding globulin (SHBG) were determined in 98 women treated with combined oral…”
Get more information

Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women by Fåhraeus, L, Larsson-Cohn, U, Wallentin, L

“…Thirty-eight post-menopausal women were randomly allocated to substitution treatment with either oestradiol-17 beta orally (2-4 mg) or cutaneously (3 mg). The…”
Get more information

Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women by Fåhraeus, L, Larsson-Cohn, U, Ljungberg, S, Wallentin, L

“…Twelve women with pelvic endometriosis were treated with 600 mg of danazol daily for 24 weeks. The molar and fractional lecithin:cholesterol acyl transfer…”
Get more information

Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhoea? by Rydén, G, Fåhraeus, L, Molin, L, Ahman, K

“…The influence of different contraceptive techniques on the incidence of pelvic inflammatory disease (PID) in 672 patients with gonorrhoea have been studied…”
Get more information

The effects of estradiol on blood lipids and lipoproteins in postmenopausal women by Fåhraeus, L

“…Endogenous sex steroids seem to exert a major influence on plasma lipoprotein levels. During menopause, endogenous estradiol (E2) levels decrease, and the…”
Get more information

Placental transfer of furosemide by Beermann, B, Groschinsky-Grind, M, Fåhraeus, L, Lindström, B

“…After oral administration of furosemide to 18 pregnant women on the day of delivery, substantial concentrations of the drug were detected in umbilical cord…”
Get more information

Cholesterol esterification rate and its relation to lipoprotein levels in plasma in normal human pregnancy by Wallentin, L, Fåhraeus, L

“…The lecithin:cholesterol acyl transfer (LCAT) reaction produces cholesteryl esters and lysolecithin in plasma. The rate of LCAT is related to the plasma…”
Get more information

High density lipoprotein subfractions during oral and cutaneous administration of 17 beta-estradiol to menopausal women by Fåhraeus, L, Wallentin, L

“…Thirty eight women with menopausal vasomotor symptoms were randomly allocated to 6 months treatment with either 2-4 mg micronized estradiol given orally or 3…”
Get more information

Climacteric symptoms in an unselected sample of Swedish women by Hammar, M, Berg, G, Fåhraeus, L, Larsson-Cohn, U

“…A questionnaire on climacteric symptoms was sent to every woman living in the city of Linköping, Sweden (120,000 inhabitants) who was born in 1928 or 1930. Of…”
Get more information